NXG Stock Overview
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
NexgenRx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.20 |
| 52 Week High | CA$0.33 |
| 52 Week Low | CA$0.17 |
| Beta | 0.23 |
| 1 Month Change | -4.76% |
| 3 Month Change | -9.09% |
| 1 Year Change | n/a |
| 3 Year Change | -45.95% |
| 5 Year Change | -25.93% |
| Change since IPO | -42.86% |
Recent News & Updates
Recent updates
NexgenRx Inc.'s (CVE:NXG) Price Is Out Of Tune With Revenues
Mar 14
Here's Why We Think NexgenRx (CVE:NXG) Might Deserve Your Attention Today
Mar 07Is Now The Time To Put NexgenRx (CVE:NXG) On Your Watchlist?
Oct 18Does NexgenRx (CVE:NXG) Deserve A Spot On Your Watchlist?
Nov 30What NexgenRx Inc.'s (CVE:NXG) 32% Share Price Gain Is Not Telling You
Aug 24Here's Why NexgenRx Inc.'s (CVE:NXG) CEO May Have Their Pay Bumped Up
Jun 03NexgenRx Inc.'s (CVE:NXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 19
How Much Is NexgenRx's (CVE:NXG) CEO Getting Paid?
Dec 28Shareholder Returns
| NXG | CA Insurance | CA Market | |
|---|---|---|---|
| 7D | -9.1% | -1.4% | -2.1% |
| 1Y | n/a | 14.7% | 3.6% |
Return vs Industry: Insufficient data to determine how NXG performed against the Canadian Insurance industry.
Return vs Market: Insufficient data to determine how NXG performed against the Canadian Market.
Price Volatility
| NXG volatility | |
|---|---|
| NXG Average Weekly Movement | n/a |
| Insurance Industry Average Movement | 3.1% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: NXG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NXG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Ron Loucks | www.nexgenrx.com |
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
NexgenRx Inc. Fundamentals Summary
| NXG fundamental statistics | |
|---|---|
| Market cap | CA$14.18m |
| Earnings (TTM) | -CA$331.97k |
| Revenue (TTM) | CA$13.85m |
1.0x
P/S Ratio-42.7x
P/E RatioIs NXG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXG income statement (TTM) | |
|---|---|
| Revenue | CA$13.85m |
| Cost of Revenue | CA$3.03m |
| Gross Profit | CA$10.82m |
| Other Expenses | CA$11.15m |
| Earnings | -CA$331.97k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0047 |
| Gross Margin | 78.14% |
| Net Profit Margin | -2.40% |
| Debt/Equity Ratio | 0% |
How did NXG perform over the long term?
See historical performance and comparison